Compounds > emodin

emodin and dichlororibofuranosylbenzimidazole

emodin has been researched along with dichlororibofuranosylbenzimidazole in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G1
Hirasawa, A; Kinoshita, T; Kitaura, K; Nakanishi, I; Nakaniwa, T; Sekiguchi, Y; Tada, T; Tsujimoto, G1
Anderes, K; Bliesath, J; Bourbon, P; Chen, TK; Chua, PC; Darjania, L; Drygin, D; Haddach, M; Ho, C; Michaux, J; Nagasawa, J; O'Brien, SE; Omori, M; Pierre, F; Proffitt, C; Rice, WG; Ryckman, DM; Schwaebe, MK; Siddiqui-Jain, A; Stansfield, R; Stefan, E; Streiner, N; Trent, K; Vialettes, A; Whitten, JP1
Bednarski, P; Götz, C; Hemmerling, HJ; Hundsdörfer, C; Jose, J; Le Borgne, M; Totzke, F1
Bech-Otschir, D; Berse, M; Dubiel, W; Dumdey, R; Henklein, P; Huang, X; Medalia, O; Schade, R; Sperling, J; Uhle, S; Waldron, R1
He, G; Kurokawa, T; Siddik, ZH1

Other Studies

6 other study(ies) available for emodin and dichlororibofuranosylbenzimidazole

ArticleYear
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    The Biochemical journal, 2003, Sep-15, Volume: 374, Issue:Pt 3

    Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays

2003
Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Bioorganic & medicinal chemistry letters, 2009, Jun-01, Volume: 19, Issue:11

    Topics: Adenosine Triphosphate; Binding Sites; Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Ellagic Acid; Enzyme Inhibitors; Humans; Protein Structure, Tertiary

2009
Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.
    Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding, Competitive; Biological Availability; Casein Kinase II; Cell Line, Tumor; Dogs; Drug Screening Assays, Antitumor; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Inbred ICR; Mice, Nude; Models, Molecular; Naphthyridines; Neoplasm Transplantation; Phenazines; Rats; Structure-Activity Relationship; Transplantation, Heterologous

2011
Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
    Bioorganic & medicinal chemistry, 2012, Apr-01, Volume: 20, Issue:7

    Topics: Casein Kinase II; Cell Membrane Permeability; Humans; Indoles; Kinetics; Protein Kinase Inhibitors; Stereoisomerism

2012
Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome.
    The EMBO journal, 2003, Mar-17, Volume: 22, Issue:6

    Topics: Adenosine Triphosphate; Casein Kinase II; COP9 Signalosome Complex; Curcumin; Dichlororibofuranosylbenzimidazole; DNA-Binding Proteins; Emodin; Enzyme Inhibitors; Erythrocytes; HeLa Cells; Humans; Multiprotein Complexes; Peptide Hydrolases; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Protein Subunits; Proteins; Proto-Oncogene Proteins c-jun; Recombinant Proteins; Resveratrol; Signal Transduction; Stilbenes; Substrate Specificity; Tumor Suppressor Protein p53; Ubiquitins

2003
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3

    Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Copper Transporter 1; Dichlororibofuranosylbenzimidazole; DNA Adducts; Dose-Response Relationship, Drug; Drug Synergism; Emodin; Female; Humans; Inhibitory Concentration 50; Intracellular Space; Nucleic Acid Synthesis Inhibitors; Ovarian Neoplasms; Protein Kinase Inhibitors; RNA Interference; Spectrophotometry, Atomic; Time Factors

2010